Fig. 2From: A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients111In-OTSA-101 visual uptake grading. Examples of 111In-OTSA-101 tumors uptake visualized in 3 patients on planar imaging (a) and assessed using visual scale applied on SPECT-CT acquisitions (b)Back to article page